Mylan Pushes 3rd Circ. To Revive Doryx Product-Hopping Suit
Generic-drug maker Mylan Pharmaceuticals Inc. urged the Third Circuit on Tuesday to resurrect its suit against Warner Chilcott PLC for allegedly tweaking the formula of its acne medication Doryx in order...To view the full article, register now.
Already a subscriber? Click here to view full article